Palliative Care in Chronic Respiratory Failure
A special issue of Medicina (ISSN 1648-9144).
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 529
Special Issue Editor
Special Issue Information
Dear Colleagues,
Palliative care is still primarily focused on oncological conditions, where the main goal is to relieve pain and other symptoms while also improving quality of life.
Chronic conditions, however, have only recently had their specific palliative care needs to be recognized, and it is usually the end-stage chronic disease which triggers the consideration of this type of care as a component of the management.
Chronic respiratory failure is the common denominator of all chronic pulmonary diseases and can be considered an end-stage organ disease such as chronic heart failure, etc. Most commonly, it develops as a result of chronic obstructive pulmonary disease (COPD) or interstitial lung diseases of various etiologies including, more recently, COVID-19.
Palliative care in chronic respiratory failure could be another rather generic manner to consider this approach, instead of the more accepted disease-specific one. In chronic respiratory failure, palliative care can be applied in a more proactive way, i.e., as soon as it is diagnosed, or it can be applied at the end of life.
I invite you to submit papers regarding this topic, and I encourage you to contribute with research that can help to improve the palliative care of patients with chronic respiratory conditions leading to chronic respiratory failure
Prof. Dr. Sabina Antoniu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- chronic respiratory failure
- chronic obstructive pulmonary disease
- interstitial lung disease
- post-COVID 19 pulmonary sequelae
- quality of life
- palliative care
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
